- The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
Huijie Jia et al, 2018, International Journal of Oncology CrossRef - A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption
Ahmed E. Khodir et al, 2020, Life Sciences CrossRef - Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis
Xingping Su et al, 2023, European Journal of Medicinal Chemistry CrossRef - COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
Mohamed M. Aboudounya et al, 2021, Mediators of Inflammation CrossRef - MicroRNAs as Potential Diagnostic, Prognostic, and Predictive Biomarkers for Acute Graft-versus-Host Disease
Jamshid Motaei et al, 2019, Biology of Blood and Marrow Transplantation CrossRef - Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms
Hanan S. Althagafy et al, 2023, European Journal of Pharmacology CrossRef - Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NFκB, oxidative stress, and apoptosis
Nehal M. Elsherbiny et al, 2018, Toxicology Mechanisms and Methods CrossRef - Screening a small hydrazide-hydrazone combinatorial library for targeting the STAT3 in monocyte-macrophages with insulated reporter transposons
Valeri V. Mossine et al, 2023, Medicinal Chemistry Research CrossRef - Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK/caspase-8/TRAIL activation in rats
Ahmed E. Khodir et al, 2020, Life Sciences CrossRef - Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight
Fares E.M. Ali et al, 2021, Life Sciences CrossRef - T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
Julia Campe et al, 2022, Frontiers in Immunology CrossRef - Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment
Christian Bailly, 2019, Drug Discovery Today CrossRef - Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
Rebecca Harris et al, 2023, Frontiers in Immunology CrossRef - The interplay of the inhibitory effect of nifuroxazide on NF-κB/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats
Yousra M. El-Far et al, 2020, Environmental Toxicology and Pharmacology CrossRef - STAT signaling in the intestine
Yael R. Nobel et al, 2021, Signal Transduction in Cancer and Immunity CrossRef - IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma Growth
Tiesuo Zhao et al, 2023, Current Molecular Pharmacology CrossRef - Combination of attenuated Salmonella carrying PD‐1 siRNA with nifuroxazide for colon cancer therapy
Tiesuo Zhao et al, 2020, Journal of Cellular Biochemistry CrossRef